nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—ABCB1—Dactinomycin—sarcoma	0.0319	0.289	CbGbCtD
Lamotrigine—ABCB1—Mitoxantrone—sarcoma	0.0285	0.259	CbGbCtD
Lamotrigine—ABCB1—Vincristine—sarcoma	0.0196	0.178	CbGbCtD
Lamotrigine—ABCB1—Etoposide—sarcoma	0.018	0.163	CbGbCtD
Lamotrigine—ABCB1—Doxorubicin—sarcoma	0.0123	0.111	CbGbCtD
Lamotrigine—SCN3A—Axon guidance—PTPRC—sarcoma	0.000792	0.00494	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MYOD1—sarcoma	0.000781	0.00487	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—PLCG1—sarcoma	0.000775	0.00483	CbGpPWpGaD
Lamotrigine—SCN8A—L1CAM interactions—EGFR—sarcoma	0.000771	0.00481	CbGpPWpGaD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000769	0.0048	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—PTPRC—sarcoma	0.000761	0.00474	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—PTPRC—sarcoma	0.000761	0.00474	CbGpPWpGaD
Lamotrigine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000754	0.0047	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MYOD1—sarcoma	0.000751	0.00468	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MYOD1—sarcoma	0.000751	0.00468	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—PLCG1—sarcoma	0.000744	0.00464	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—PLCG1—sarcoma	0.000744	0.00464	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—PTPRC—sarcoma	0.000733	0.00457	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—PTPRC—sarcoma	0.000733	0.00457	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—PTPRC—sarcoma	0.00073	0.00455	CbGpPWpGaD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.00073	0.00455	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MYOD1—sarcoma	0.000724	0.00451	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MYOD1—sarcoma	0.000724	0.00451	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—PLCG1—sarcoma	0.000718	0.00448	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—PLCG1—sarcoma	0.000718	0.00448	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—PLCG1—sarcoma	0.000715	0.00446	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—SRC—sarcoma	0.000712	0.00444	CbGpPWpGaD
Lamotrigine—SCN3A—L1CAM interactions—SRC—sarcoma	0.000681	0.00424	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—SRC—sarcoma	0.000654	0.00408	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—SRC—sarcoma	0.000654	0.00408	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—SRC—sarcoma	0.000631	0.00393	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—SRC—sarcoma	0.000631	0.00393	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EZR—sarcoma	0.000624	0.00389	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—EGFR—sarcoma	0.000624	0.00389	CbGpPWpGaD
Lamotrigine—SCN3A—L1CAM interactions—EGFR—sarcoma	0.000597	0.00372	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—PTPRC—sarcoma	0.000591	0.00368	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—KDR—sarcoma	0.000588	0.00367	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—PLCG1—sarcoma	0.000578	0.0036	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—EGFR—sarcoma	0.000573	0.00357	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—EGFR—sarcoma	0.000573	0.00357	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000572	0.00357	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—PTPRC—sarcoma	0.000565	0.00352	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—PLCG1—sarcoma	0.000553	0.00345	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—EGFR—sarcoma	0.000553	0.00345	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—EGFR—sarcoma	0.000553	0.00345	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—PTPRC—sarcoma	0.000543	0.00339	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—PTPRC—sarcoma	0.000543	0.00339	CbGpPWpGaD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000535	0.00334	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—PLCG1—sarcoma	0.000531	0.00331	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—PLCG1—sarcoma	0.000531	0.00331	CbGpPWpGaD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000527	0.00329	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—PTPRC—sarcoma	0.000523	0.00326	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—PTPRC—sarcoma	0.000523	0.00326	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—PTPRC—sarcoma	0.000516	0.00322	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—CREB1—sarcoma	0.000515	0.00321	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—PLCG1—sarcoma	0.000512	0.00319	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—PLCG1—sarcoma	0.000512	0.00319	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MYOD1—sarcoma	0.000509	0.00317	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—FOXO1—sarcoma	0.000507	0.00316	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—PLCG1—sarcoma	0.000505	0.00315	CbGpPWpGaD
Lamotrigine—Photosensitivity reaction—Epirubicin—sarcoma	0.000502	0.000689	CcSEcCtD
Lamotrigine—Paraesthesia—Etoposide—sarcoma	0.000501	0.000687	CcSEcCtD
Lamotrigine—Weight increased—Epirubicin—sarcoma	0.000501	0.000687	CcSEcCtD
Lamotrigine—Pancreatitis—Doxorubicin—sarcoma	0.000499	0.000685	CcSEcCtD
Lamotrigine—Weight decreased—Epirubicin—sarcoma	0.000498	0.000683	CcSEcCtD
Lamotrigine—Dyspnoea—Etoposide—sarcoma	0.000498	0.000683	CcSEcCtD
Lamotrigine—Hyperglycaemia—Epirubicin—sarcoma	0.000497	0.000681	CcSEcCtD
Lamotrigine—Somnolence—Etoposide—sarcoma	0.000496	0.000681	CcSEcCtD
Lamotrigine—Angina pectoris—Doxorubicin—sarcoma	0.000496	0.00068	CcSEcCtD
Lamotrigine—Hypersensitivity—Mitoxantrone—sarcoma	0.000495	0.000678	CcSEcCtD
Lamotrigine—Asthenia—Vincristine—sarcoma	0.000495	0.000678	CcSEcCtD
Lamotrigine—Vomiting—Thiotepa—sarcoma	0.000494	0.000678	CcSEcCtD
Lamotrigine—Pneumonia—Epirubicin—sarcoma	0.000494	0.000677	CcSEcCtD
Lamotrigine—Drowsiness—Epirubicin—sarcoma	0.000491	0.000673	CcSEcCtD
Lamotrigine—Infestation NOS—Epirubicin—sarcoma	0.000491	0.000673	CcSEcCtD
Lamotrigine—Infestation—Epirubicin—sarcoma	0.000491	0.000673	CcSEcCtD
Lamotrigine—Vomiting—Dactinomycin—sarcoma	0.000491	0.000673	CcSEcCtD
Lamotrigine—Rash—Thiotepa—sarcoma	0.00049	0.000672	CcSEcCtD
Lamotrigine—Bronchitis—Doxorubicin—sarcoma	0.00049	0.000672	CcSEcCtD
Lamotrigine—Dermatitis—Thiotepa—sarcoma	0.00049	0.000671	CcSEcCtD
Lamotrigine—Headache—Thiotepa—sarcoma	0.000487	0.000668	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000487	0.000667	CcSEcCtD
Lamotrigine—Rash—Dactinomycin—sarcoma	0.000486	0.000667	CcSEcCtD
Lamotrigine—Decreased appetite—Etoposide—sarcoma	0.000485	0.000666	CcSEcCtD
Lamotrigine—Pancytopenia—Doxorubicin—sarcoma	0.000484	0.000663	CcSEcCtD
Lamotrigine—Renal failure—Epirubicin—sarcoma	0.000482	0.000661	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Etoposide—sarcoma	0.000482	0.000661	CcSEcCtD
Lamotrigine—Asthenia—Mitoxantrone—sarcoma	0.000482	0.00066	CcSEcCtD
Lamotrigine—Fatigue—Etoposide—sarcoma	0.000481	0.00066	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Epirubicin—sarcoma	0.000481	0.00066	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—MMP2—sarcoma	0.00048	0.00299	CbGpPWpGaD
Lamotrigine—Stomatitis—Epirubicin—sarcoma	0.000478	0.000656	CcSEcCtD
Lamotrigine—Pain—Etoposide—sarcoma	0.000478	0.000655	CcSEcCtD
Lamotrigine—Constipation—Etoposide—sarcoma	0.000478	0.000655	CcSEcCtD
Lamotrigine—Urinary tract infection—Epirubicin—sarcoma	0.000477	0.000654	CcSEcCtD
Lamotrigine—Conjunctivitis—Epirubicin—sarcoma	0.000477	0.000654	CcSEcCtD
Lamotrigine—Neutropenia—Doxorubicin—sarcoma	0.000476	0.000653	CcSEcCtD
Lamotrigine—Dysuria—Doxorubicin—sarcoma	0.000476	0.000653	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—KDR—sarcoma	0.000475	0.00296	CbGpPWpGaD
Lamotrigine—Diarrhoea—Vincristine—sarcoma	0.000472	0.000647	CcSEcCtD
Lamotrigine—Sweating—Epirubicin—sarcoma	0.000471	0.000645	CcSEcCtD
Lamotrigine—Pollakiuria—Doxorubicin—sarcoma	0.000471	0.000645	CcSEcCtD
Lamotrigine—Haematuria—Epirubicin—sarcoma	0.000468	0.000642	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000466	0.00291	CbGpPWpGaD
Lamotrigine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000465	0.000637	CcSEcCtD
Lamotrigine—Weight increased—Doxorubicin—sarcoma	0.000464	0.000636	CcSEcCtD
Lamotrigine—Epistaxis—Epirubicin—sarcoma	0.000463	0.000635	CcSEcCtD
Lamotrigine—Nausea—Thiotepa—sarcoma	0.000462	0.000633	CcSEcCtD
Lamotrigine—Weight decreased—Doxorubicin—sarcoma	0.000461	0.000632	CcSEcCtD
Lamotrigine—Sinusitis—Epirubicin—sarcoma	0.00046	0.000631	CcSEcCtD
Lamotrigine—Feeling abnormal—Etoposide—sarcoma	0.00046	0.000631	CcSEcCtD
Lamotrigine—Hyperglycaemia—Doxorubicin—sarcoma	0.000459	0.00063	CcSEcCtD
Lamotrigine—Diarrhoea—Mitoxantrone—sarcoma	0.000459	0.00063	CcSEcCtD
Lamotrigine—Nausea—Dactinomycin—sarcoma	0.000458	0.000628	CcSEcCtD
Lamotrigine—Agranulocytosis—Epirubicin—sarcoma	0.000458	0.000628	CcSEcCtD
Lamotrigine—Pneumonia—Doxorubicin—sarcoma	0.000457	0.000626	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Etoposide—sarcoma	0.000457	0.000626	CcSEcCtD
Lamotrigine—Dizziness—Vincristine—sarcoma	0.000456	0.000625	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—KDR—sarcoma	0.000455	0.00284	CbGpPWpGaD
Lamotrigine—Infestation—Doxorubicin—sarcoma	0.000454	0.000623	CcSEcCtD
Lamotrigine—Drowsiness—Doxorubicin—sarcoma	0.000454	0.000623	CcSEcCtD
Lamotrigine—Infestation NOS—Doxorubicin—sarcoma	0.000454	0.000623	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00045	0.000617	CcSEcCtD
Lamotrigine—Renal failure—Doxorubicin—sarcoma	0.000446	0.000612	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000445	0.00061	CcSEcCtD
Lamotrigine—Urticaria—Etoposide—sarcoma	0.000444	0.000608	CcSEcCtD
Lamotrigine—SCN5A—L1CAM interactions—SRC—sarcoma	0.000443	0.00276	CbGpPWpGaD
Lamotrigine—Haemoglobin—Epirubicin—sarcoma	0.000443	0.000607	CcSEcCtD
Lamotrigine—Stomatitis—Doxorubicin—sarcoma	0.000443	0.000607	CcSEcCtD
Lamotrigine—Rhinitis—Epirubicin—sarcoma	0.000442	0.000606	CcSEcCtD
Lamotrigine—Abdominal pain—Etoposide—sarcoma	0.000441	0.000605	CcSEcCtD
Lamotrigine—Body temperature increased—Etoposide—sarcoma	0.000441	0.000605	CcSEcCtD
Lamotrigine—Urinary tract infection—Doxorubicin—sarcoma	0.000441	0.000605	CcSEcCtD
Lamotrigine—Conjunctivitis—Doxorubicin—sarcoma	0.000441	0.000605	CcSEcCtD
Lamotrigine—Hepatitis—Epirubicin—sarcoma	0.000441	0.000604	CcSEcCtD
Lamotrigine—Haemorrhage—Epirubicin—sarcoma	0.000441	0.000604	CcSEcCtD
Lamotrigine—Hypoaesthesia—Epirubicin—sarcoma	0.000438	0.000601	CcSEcCtD
Lamotrigine—Vomiting—Vincristine—sarcoma	0.000438	0.000601	CcSEcCtD
Lamotrigine—Pharyngitis—Epirubicin—sarcoma	0.000437	0.0006	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—KDR—sarcoma	0.000437	0.00272	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—KDR—sarcoma	0.000437	0.00272	CbGpPWpGaD
Lamotrigine—Sweating—Doxorubicin—sarcoma	0.000435	0.000597	CcSEcCtD
Lamotrigine—Rash—Vincristine—sarcoma	0.000435	0.000596	CcSEcCtD
Lamotrigine—Dermatitis—Vincristine—sarcoma	0.000434	0.000595	CcSEcCtD
Lamotrigine—Oedema peripheral—Epirubicin—sarcoma	0.000434	0.000595	CcSEcCtD
Lamotrigine—Haematuria—Doxorubicin—sarcoma	0.000433	0.000594	CcSEcCtD
Lamotrigine—Connective tissue disorder—Epirubicin—sarcoma	0.000433	0.000594	CcSEcCtD
Lamotrigine—Headache—Vincristine—sarcoma	0.000432	0.000592	CcSEcCtD
Lamotrigine—Epistaxis—Doxorubicin—sarcoma	0.000428	0.000587	CcSEcCtD
Lamotrigine—Vomiting—Mitoxantrone—sarcoma	0.000427	0.000585	CcSEcCtD
Lamotrigine—Sinusitis—Doxorubicin—sarcoma	0.000426	0.000584	CcSEcCtD
Lamotrigine—Agranulocytosis—Doxorubicin—sarcoma	0.000424	0.000581	CcSEcCtD
Lamotrigine—Rash—Mitoxantrone—sarcoma	0.000423	0.00058	CcSEcCtD
Lamotrigine—Dermatitis—Mitoxantrone—sarcoma	0.000423	0.00058	CcSEcCtD
Lamotrigine—SCN10A—Axon guidance—KDR—sarcoma	0.000421	0.00263	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—KDR—sarcoma	0.000421	0.00263	CbGpPWpGaD
Lamotrigine—Headache—Mitoxantrone—sarcoma	0.000421	0.000577	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—KDR—sarcoma	0.000419	0.00262	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—CREB1—sarcoma	0.000417	0.0026	CbGpPWpGaD
Lamotrigine—Erythema multiforme—Epirubicin—sarcoma	0.000417	0.000571	CcSEcCtD
Lamotrigine—Eye disorder—Epirubicin—sarcoma	0.000412	0.000565	CcSEcCtD
Lamotrigine—Hypersensitivity—Etoposide—sarcoma	0.000411	0.000564	CcSEcCtD
Lamotrigine—Tinnitus—Epirubicin—sarcoma	0.000411	0.000563	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—FOXO1—sarcoma	0.00041	0.00256	CbGpPWpGaD
Lamotrigine—Haemoglobin—Doxorubicin—sarcoma	0.00041	0.000562	CcSEcCtD
Lamotrigine—Nausea—Vincristine—sarcoma	0.000409	0.000561	CcSEcCtD
Lamotrigine—Flushing—Epirubicin—sarcoma	0.000409	0.000561	CcSEcCtD
Lamotrigine—Rhinitis—Doxorubicin—sarcoma	0.000409	0.00056	CcSEcCtD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000409	0.00255	CbGpPWpGaD
Lamotrigine—Haemorrhage—Doxorubicin—sarcoma	0.000408	0.000559	CcSEcCtD
Lamotrigine—Hepatitis—Doxorubicin—sarcoma	0.000408	0.000559	CcSEcCtD
Lamotrigine—Hypoaesthesia—Doxorubicin—sarcoma	0.000406	0.000556	CcSEcCtD
Lamotrigine—Pharyngitis—Doxorubicin—sarcoma	0.000405	0.000555	CcSEcCtD
Lamotrigine—Oedema peripheral—Doxorubicin—sarcoma	0.000402	0.000551	CcSEcCtD
Lamotrigine—Asthenia—Etoposide—sarcoma	0.000401	0.000549	CcSEcCtD
Lamotrigine—Connective tissue disorder—Doxorubicin—sarcoma	0.000401	0.000549	CcSEcCtD
Lamotrigine—Angiopathy—Epirubicin—sarcoma	0.0004	0.000548	CcSEcCtD
Lamotrigine—Nausea—Mitoxantrone—sarcoma	0.000399	0.000547	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—CREB1—sarcoma	0.000399	0.00249	CbGpPWpGaD
Lamotrigine—Mediastinal disorder—Epirubicin—sarcoma	0.000397	0.000544	CcSEcCtD
Lamotrigine—Chills—Epirubicin—sarcoma	0.000395	0.000542	CcSEcCtD
Lamotrigine—Pruritus—Etoposide—sarcoma	0.000395	0.000542	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—FOXO1—sarcoma	0.000392	0.00245	CbGpPWpGaD
Lamotrigine—Alopecia—Epirubicin—sarcoma	0.000389	0.000534	CcSEcCtD
Lamotrigine—SCN5A—L1CAM interactions—EGFR—sarcoma	0.000389	0.00242	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MMP2—sarcoma	0.000388	0.00242	CbGpPWpGaD
Lamotrigine—Mental disorder—Epirubicin—sarcoma	0.000386	0.000529	CcSEcCtD
Lamotrigine—Erythema multiforme—Doxorubicin—sarcoma	0.000385	0.000528	CcSEcCtD
Lamotrigine—Malnutrition—Epirubicin—sarcoma	0.000384	0.000526	CcSEcCtD
Lamotrigine—Erythema—Epirubicin—sarcoma	0.000384	0.000526	CcSEcCtD
Lamotrigine—SCN2A—Axon guidance—CREB1—sarcoma	0.000383	0.00239	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—CREB1—sarcoma	0.000383	0.00239	CbGpPWpGaD
Lamotrigine—Diarrhoea—Etoposide—sarcoma	0.000382	0.000524	CcSEcCtD
Lamotrigine—Eye disorder—Doxorubicin—sarcoma	0.000381	0.000522	CcSEcCtD
Lamotrigine—Tinnitus—Doxorubicin—sarcoma	0.00038	0.000521	CcSEcCtD
Lamotrigine—Flushing—Doxorubicin—sarcoma	0.000378	0.000519	CcSEcCtD
Lamotrigine—Flatulence—Epirubicin—sarcoma	0.000378	0.000518	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—FOXO1—sarcoma	0.000377	0.00235	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—FOXO1—sarcoma	0.000377	0.00235	CbGpPWpGaD
Lamotrigine—Tension—Epirubicin—sarcoma	0.000376	0.000516	CcSEcCtD
Lamotrigine—Dysgeusia—Epirubicin—sarcoma	0.000376	0.000515	CcSEcCtD
Lamotrigine—Nervousness—Epirubicin—sarcoma	0.000373	0.000511	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—MMP2—sarcoma	0.000371	0.00231	CbGpPWpGaD
Lamotrigine—Back pain—Epirubicin—sarcoma	0.000371	0.000509	CcSEcCtD
Lamotrigine—Angiopathy—Doxorubicin—sarcoma	0.00037	0.000507	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—CREB1—sarcoma	0.000369	0.0023	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—CREB1—sarcoma	0.000369	0.0023	CbGpPWpGaD
Lamotrigine—Dizziness—Etoposide—sarcoma	0.000369	0.000506	CcSEcCtD
Lamotrigine—Muscle spasms—Epirubicin—sarcoma	0.000369	0.000506	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000368	0.00229	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—CREB1—sarcoma	0.000368	0.00229	CbGpPWpGaD
Lamotrigine—Mediastinal disorder—Doxorubicin—sarcoma	0.000367	0.000504	CcSEcCtD
Lamotrigine—Chills—Doxorubicin—sarcoma	0.000366	0.000502	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—FOXO1—sarcoma	0.000363	0.00227	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—FOXO1—sarcoma	0.000363	0.00227	CbGpPWpGaD
Lamotrigine—Vision blurred—Epirubicin—sarcoma	0.000361	0.000496	CcSEcCtD
Lamotrigine—Alopecia—Doxorubicin—sarcoma	0.00036	0.000494	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—PLCG1—sarcoma	0.00036	0.00225	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—PDGFRA—sarcoma	0.00036	0.00224	CbGpPWpGaD
Lamotrigine—Mental disorder—Doxorubicin—sarcoma	0.000357	0.00049	CcSEcCtD
Lamotrigine—SCN2A—Axon guidance—MMP2—sarcoma	0.000357	0.00222	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MMP2—sarcoma	0.000357	0.00222	CbGpPWpGaD
Lamotrigine—Ill-defined disorder—Epirubicin—sarcoma	0.000356	0.000488	CcSEcCtD
Lamotrigine—Vomiting—Etoposide—sarcoma	0.000355	0.000487	CcSEcCtD
Lamotrigine—Malnutrition—Doxorubicin—sarcoma	0.000355	0.000487	CcSEcCtD
Lamotrigine—Erythema—Doxorubicin—sarcoma	0.000355	0.000487	CcSEcCtD
Lamotrigine—Anaemia—Epirubicin—sarcoma	0.000355	0.000486	CcSEcCtD
Lamotrigine—Agitation—Epirubicin—sarcoma	0.000352	0.000483	CcSEcCtD
Lamotrigine—Rash—Etoposide—sarcoma	0.000352	0.000483	CcSEcCtD
Lamotrigine—Dermatitis—Etoposide—sarcoma	0.000352	0.000482	CcSEcCtD
Lamotrigine—Headache—Etoposide—sarcoma	0.00035	0.00048	CcSEcCtD
Lamotrigine—Flatulence—Doxorubicin—sarcoma	0.00035	0.000479	CcSEcCtD
Lamotrigine—Tension—Doxorubicin—sarcoma	0.000348	0.000477	CcSEcCtD
Lamotrigine—Dysgeusia—Doxorubicin—sarcoma	0.000348	0.000476	CcSEcCtD
Lamotrigine—Malaise—Epirubicin—sarcoma	0.000346	0.000474	CcSEcCtD
Lamotrigine—Nervousness—Doxorubicin—sarcoma	0.000345	0.000473	CcSEcCtD
Lamotrigine—Vertigo—Epirubicin—sarcoma	0.000345	0.000472	CcSEcCtD
Lamotrigine—Syncope—Epirubicin—sarcoma	0.000344	0.000472	CcSEcCtD
Lamotrigine—SCN10A—Axon guidance—MMP2—sarcoma	0.000344	0.00214	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MMP2—sarcoma	0.000344	0.00214	CbGpPWpGaD
Lamotrigine—Leukopenia—Epirubicin—sarcoma	0.000343	0.000471	CcSEcCtD
Lamotrigine—Back pain—Doxorubicin—sarcoma	0.000343	0.000471	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—MMP2—sarcoma	0.000342	0.00214	CbGpPWpGaD
Lamotrigine—Muscle spasms—Doxorubicin—sarcoma	0.000341	0.000468	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—KDR—sarcoma	0.000339	0.00212	CbGpPWpGaD
Lamotrigine—Palpitations—Epirubicin—sarcoma	0.000339	0.000465	CcSEcCtD
Lamotrigine—Loss of consciousness—Epirubicin—sarcoma	0.000337	0.000462	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000335	0.00209	CbGpPWpGaD
Lamotrigine—Cough—Epirubicin—sarcoma	0.000335	0.000459	CcSEcCtD
Lamotrigine—Vision blurred—Doxorubicin—sarcoma	0.000334	0.000459	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000334	0.00209	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000333	0.00207	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—SRC—sarcoma	0.000333	0.00207	CbGpPWpGaD
Lamotrigine—Convulsion—Epirubicin—sarcoma	0.000332	0.000456	CcSEcCtD
Lamotrigine—Nausea—Etoposide—sarcoma	0.000332	0.000455	CcSEcCtD
Lamotrigine—Hypertension—Epirubicin—sarcoma	0.000331	0.000454	CcSEcCtD
Lamotrigine—Ill-defined disorder—Doxorubicin—sarcoma	0.000329	0.000451	CcSEcCtD
Lamotrigine—Anaemia—Doxorubicin—sarcoma	0.000328	0.00045	CcSEcCtD
Lamotrigine—Arthralgia—Epirubicin—sarcoma	0.000327	0.000448	CcSEcCtD
Lamotrigine—Chest pain—Epirubicin—sarcoma	0.000327	0.000448	CcSEcCtD
Lamotrigine—Myalgia—Epirubicin—sarcoma	0.000327	0.000448	CcSEcCtD
Lamotrigine—Agitation—Doxorubicin—sarcoma	0.000326	0.000447	CcSEcCtD
Lamotrigine—Anxiety—Epirubicin—sarcoma	0.000325	0.000446	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—KDR—sarcoma	0.000324	0.00202	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—VEGFA—sarcoma	0.000324	0.00202	CbGpPWpGaD
Lamotrigine—Discomfort—Epirubicin—sarcoma	0.000323	0.000442	CcSEcCtD
Lamotrigine—Malaise—Doxorubicin—sarcoma	0.00032	0.000439	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—NRAS—sarcoma	0.00032	0.00199	CbGpPWpGaD
Lamotrigine—Dry mouth—Epirubicin—sarcoma	0.000319	0.000438	CcSEcCtD
Lamotrigine—Vertigo—Doxorubicin—sarcoma	0.000319	0.000437	CcSEcCtD
Lamotrigine—Syncope—Doxorubicin—sarcoma	0.000318	0.000436	CcSEcCtD
Lamotrigine—Leukopenia—Doxorubicin—sarcoma	0.000318	0.000436	CcSEcCtD
Lamotrigine—Confusional state—Epirubicin—sarcoma	0.000316	0.000433	CcSEcCtD
Lamotrigine—Palpitations—Doxorubicin—sarcoma	0.000314	0.00043	CcSEcCtD
Lamotrigine—Oedema—Epirubicin—sarcoma	0.000313	0.000429	CcSEcCtD
Lamotrigine—Loss of consciousness—Doxorubicin—sarcoma	0.000312	0.000428	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—KDR—sarcoma	0.000312	0.00194	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—KDR—sarcoma	0.000312	0.00194	CbGpPWpGaD
Lamotrigine—Infection—Epirubicin—sarcoma	0.000311	0.000426	CcSEcCtD
Lamotrigine—Cough—Doxorubicin—sarcoma	0.00031	0.000425	CcSEcCtD
Lamotrigine—Shock—Epirubicin—sarcoma	0.000308	0.000422	CcSEcCtD
Lamotrigine—Convulsion—Doxorubicin—sarcoma	0.000307	0.000422	CcSEcCtD
Lamotrigine—Nervous system disorder—Epirubicin—sarcoma	0.000307	0.000421	CcSEcCtD
Lamotrigine—Thrombocytopenia—Epirubicin—sarcoma	0.000306	0.00042	CcSEcCtD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000306	0.00191	CbGpPWpGaD
Lamotrigine—Hypertension—Doxorubicin—sarcoma	0.000306	0.00042	CcSEcCtD
Lamotrigine—Tachycardia—Epirubicin—sarcoma	0.000306	0.000419	CcSEcCtD
Lamotrigine—Hyperhidrosis—Epirubicin—sarcoma	0.000303	0.000415	CcSEcCtD
Lamotrigine—Chest pain—Doxorubicin—sarcoma	0.000302	0.000414	CcSEcCtD
Lamotrigine—Arthralgia—Doxorubicin—sarcoma	0.000302	0.000414	CcSEcCtD
Lamotrigine—Myalgia—Doxorubicin—sarcoma	0.000302	0.000414	CcSEcCtD
Lamotrigine—Anxiety—Doxorubicin—sarcoma	0.000301	0.000413	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—KDR—sarcoma	0.000301	0.00187	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—KDR—sarcoma	0.000301	0.00187	CbGpPWpGaD
Lamotrigine—Discomfort—Doxorubicin—sarcoma	0.000299	0.000409	CcSEcCtD
Lamotrigine—Anorexia—Epirubicin—sarcoma	0.000298	0.000409	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—CREB1—sarcoma	0.000297	0.00186	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—KDR—sarcoma	0.000296	0.00185	CbGpPWpGaD
Lamotrigine—Dry mouth—Doxorubicin—sarcoma	0.000295	0.000405	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000293	0.00183	CbGpPWpGaD
Lamotrigine—Confusional state—Doxorubicin—sarcoma	0.000292	0.0004	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—EGFR—sarcoma	0.000291	0.00182	CbGpPWpGaD
Lamotrigine—Oedema—Doxorubicin—sarcoma	0.00029	0.000397	CcSEcCtD
Lamotrigine—Infection—Doxorubicin—sarcoma	0.000288	0.000395	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000285	0.000391	CcSEcCtD
Lamotrigine—Shock—Doxorubicin—sarcoma	0.000285	0.000391	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—CREB1—sarcoma	0.000285	0.00177	CbGpPWpGaD
Lamotrigine—Nervous system disorder—Doxorubicin—sarcoma	0.000284	0.000389	CcSEcCtD
Lamotrigine—Thrombocytopenia—Doxorubicin—sarcoma	0.000284	0.000389	CcSEcCtD
Lamotrigine—Insomnia—Epirubicin—sarcoma	0.000283	0.000388	CcSEcCtD
Lamotrigine—Tachycardia—Doxorubicin—sarcoma	0.000283	0.000388	CcSEcCtD
Lamotrigine—Paraesthesia—Epirubicin—sarcoma	0.000281	0.000385	CcSEcCtD
Lamotrigine—Hyperhidrosis—Doxorubicin—sarcoma	0.00028	0.000384	CcSEcCtD
Lamotrigine—Dyspnoea—Epirubicin—sarcoma	0.000279	0.000383	CcSEcCtD
Lamotrigine—Somnolence—Epirubicin—sarcoma	0.000278	0.000382	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—MMP2—sarcoma	0.000277	0.00173	CbGpPWpGaD
Lamotrigine—Anorexia—Doxorubicin—sarcoma	0.000276	0.000379	CcSEcCtD
Lamotrigine—Dyspepsia—Epirubicin—sarcoma	0.000276	0.000378	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—KRAS—sarcoma	0.000275	0.00172	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—CREB1—sarcoma	0.000273	0.0017	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CREB1—sarcoma	0.000273	0.0017	CbGpPWpGaD
Lamotrigine—Decreased appetite—Epirubicin—sarcoma	0.000272	0.000373	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00027	0.000371	CcSEcCtD
Lamotrigine—Fatigue—Epirubicin—sarcoma	0.00027	0.00037	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—SRC—sarcoma	0.000269	0.00168	CbGpPWpGaD
Lamotrigine—Pain—Epirubicin—sarcoma	0.000268	0.000367	CcSEcCtD
Lamotrigine—Constipation—Epirubicin—sarcoma	0.000268	0.000367	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—MMP2—sarcoma	0.000265	0.00165	CbGpPWpGaD
Lamotrigine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000264	0.000362	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—CREB1—sarcoma	0.000264	0.00164	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CREB1—sarcoma	0.000264	0.00164	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—CTNNB1—sarcoma	0.000263	0.00164	CbGpPWpGaD
Lamotrigine—Insomnia—Doxorubicin—sarcoma	0.000262	0.000359	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—VEGFA—sarcoma	0.000262	0.00163	CbGpPWpGaD
Lamotrigine—Paraesthesia—Doxorubicin—sarcoma	0.00026	0.000357	CcSEcCtD
Lamotrigine—SCN5A—Axon guidance—CREB1—sarcoma	0.00026	0.00162	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—NRAS—sarcoma	0.000259	0.00161	CbGpPWpGaD
Lamotrigine—Dyspnoea—Doxorubicin—sarcoma	0.000258	0.000354	CcSEcCtD
Lamotrigine—Feeling abnormal—Epirubicin—sarcoma	0.000258	0.000354	CcSEcCtD
Lamotrigine—Somnolence—Doxorubicin—sarcoma	0.000257	0.000353	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—SRC—sarcoma	0.000257	0.0016	CbGpPWpGaD
Lamotrigine—Gastrointestinal pain—Epirubicin—sarcoma	0.000256	0.000351	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—FOXO1—sarcoma	0.000256	0.00159	CbGpPWpGaD
Lamotrigine—Dyspepsia—Doxorubicin—sarcoma	0.000255	0.00035	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—MMP2—sarcoma	0.000254	0.00159	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MMP2—sarcoma	0.000254	0.00159	CbGpPWpGaD
Lamotrigine—Decreased appetite—Doxorubicin—sarcoma	0.000252	0.000345	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—VEGFA—sarcoma	0.000251	0.00156	CbGpPWpGaD
Lamotrigine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00025	0.000343	CcSEcCtD
Lamotrigine—Fatigue—Doxorubicin—sarcoma	0.00025	0.000342	CcSEcCtD
Lamotrigine—Urticaria—Epirubicin—sarcoma	0.000249	0.000341	CcSEcCtD
Lamotrigine—Pain—Doxorubicin—sarcoma	0.000248	0.00034	CcSEcCtD
Lamotrigine—Constipation—Doxorubicin—sarcoma	0.000248	0.00034	CcSEcCtD
Lamotrigine—Body temperature increased—Epirubicin—sarcoma	0.000247	0.000339	CcSEcCtD
Lamotrigine—Abdominal pain—Epirubicin—sarcoma	0.000247	0.000339	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—NRAS—sarcoma	0.000247	0.00154	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—SRC—sarcoma	0.000247	0.00154	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—SRC—sarcoma	0.000247	0.00154	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MMP2—sarcoma	0.000245	0.00153	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MMP2—sarcoma	0.000245	0.00153	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MMP2—sarcoma	0.000242	0.00151	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—VEGFA—sarcoma	0.000241	0.0015	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—VEGFA—sarcoma	0.000241	0.0015	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Doxorubicin—sarcoma	0.000239	0.000327	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—SRC—sarcoma	0.000238	0.00149	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—SRC—sarcoma	0.000238	0.00149	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—NRAS—sarcoma	0.000238	0.00148	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—NRAS—sarcoma	0.000238	0.00148	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—SRC—sarcoma	0.000237	0.00148	CbGpPWpGaD
Lamotrigine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000237	0.000325	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—EGFR—sarcoma	0.000236	0.00147	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—HRAS—sarcoma	0.000234	0.00146	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—VEGFA—sarcoma	0.000232	0.00145	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—VEGFA—sarcoma	0.000232	0.00145	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—VEGFA—sarcoma	0.000231	0.00144	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Epirubicin—sarcoma	0.000231	0.000316	CcSEcCtD
Lamotrigine—Urticaria—Doxorubicin—sarcoma	0.00023	0.000315	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—NRAS—sarcoma	0.000229	0.00143	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—NRAS—sarcoma	0.000229	0.00143	CbGpPWpGaD
Lamotrigine—Abdominal pain—Doxorubicin—sarcoma	0.000229	0.000314	CcSEcCtD
Lamotrigine—Body temperature increased—Doxorubicin—sarcoma	0.000229	0.000314	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—NRAS—sarcoma	0.000228	0.00142	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—EGFR—sarcoma	0.000225	0.00141	CbGpPWpGaD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	0.000225	0.0014	CbGpPWpGaD
Lamotrigine—Asthenia—Epirubicin—sarcoma	0.000225	0.000308	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—KRAS—sarcoma	0.000223	0.00139	CbGpPWpGaD
Lamotrigine—Pruritus—Epirubicin—sarcoma	0.000221	0.000304	CcSEcCtD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	0.00022	0.00137	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—EGFR—sarcoma	0.000217	0.00135	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—EGFR—sarcoma	0.000217	0.00135	CbGpPWpGaD
Lamotrigine—Diarrhoea—Epirubicin—sarcoma	0.000214	0.000294	CcSEcCtD
Lamotrigine—Hypersensitivity—Doxorubicin—sarcoma	0.000213	0.000293	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—KRAS—sarcoma	0.000213	0.00133	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—CTNNB1—sarcoma	0.000212	0.00132	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ENO2—sarcoma	0.000212	0.00132	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—KDR—sarcoma	0.000211	0.00132	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—HBA1—sarcoma	0.00021	0.00131	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—EGFR—sarcoma	0.000209	0.0013	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—EGFR—sarcoma	0.000209	0.0013	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—EGFR—sarcoma	0.000208	0.0013	CbGpPWpGaD
Lamotrigine—Asthenia—Doxorubicin—sarcoma	0.000208	0.000285	CcSEcCtD
Lamotrigine—Dizziness—Epirubicin—sarcoma	0.000207	0.000284	CcSEcCtD
Lamotrigine—Pruritus—Doxorubicin—sarcoma	0.000205	0.000281	CcSEcCtD
Lamotrigine—SCN2A—Axon guidance—KRAS—sarcoma	0.000205	0.00128	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—KRAS—sarcoma	0.000205	0.00128	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—CTNNB1—sarcoma	0.000203	0.00127	CbGpPWpGaD
Lamotrigine—Vomiting—Epirubicin—sarcoma	0.000199	0.000273	CcSEcCtD
Lamotrigine—Diarrhoea—Doxorubicin—sarcoma	0.000198	0.000272	CcSEcCtD
Lamotrigine—Rash—Epirubicin—sarcoma	0.000197	0.000271	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—KRAS—sarcoma	0.000197	0.00123	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—KRAS—sarcoma	0.000197	0.00123	CbGpPWpGaD
Lamotrigine—Dermatitis—Epirubicin—sarcoma	0.000197	0.00027	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—KRAS—sarcoma	0.000196	0.00123	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—IL2—sarcoma	0.000196	0.00122	CbGpPWpGaD
Lamotrigine—Headache—Epirubicin—sarcoma	0.000196	0.000269	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—CTNNB1—sarcoma	0.000195	0.00122	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CTNNB1—sarcoma	0.000195	0.00122	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000193	0.0012	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—SRC—sarcoma	0.000192	0.0012	CbGpPWpGaD
Lamotrigine—Dizziness—Doxorubicin—sarcoma	0.000192	0.000263	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—HRAS—sarcoma	0.000189	0.00118	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CTNNB1—sarcoma	0.000188	0.00117	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CTNNB1—sarcoma	0.000188	0.00117	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—VEGFA—sarcoma	0.000187	0.00117	CbGpPWpGaD
Lamotrigine—Nausea—Epirubicin—sarcoma	0.000186	0.000255	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—CREB1—sarcoma	0.000185	0.00116	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—NRAS—sarcoma	0.000185	0.00115	CbGpPWpGaD
Lamotrigine—Vomiting—Doxorubicin—sarcoma	0.000184	0.000252	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—SRC—sarcoma	0.000184	0.00114	CbGpPWpGaD
Lamotrigine—Rash—Doxorubicin—sarcoma	0.000183	0.00025	CcSEcCtD
Lamotrigine—Dermatitis—Doxorubicin—sarcoma	0.000182	0.00025	CcSEcCtD
Lamotrigine—Headache—Doxorubicin—sarcoma	0.000181	0.000249	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—HRAS—sarcoma	0.000181	0.00113	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PLCG1—sarcoma	0.00018	0.00112	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—VEGFA—sarcoma	0.000179	0.00111	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000177	0.00111	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—NRAS—sarcoma	0.000177	0.0011	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—SRC—sarcoma	0.000176	0.0011	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—SRC—sarcoma	0.000176	0.0011	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ENO2—sarcoma	0.000176	0.0011	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—HBA1—sarcoma	0.000175	0.00109	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—HRAS—sarcoma	0.000174	0.00108	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—HRAS—sarcoma	0.000174	0.00108	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MMP2—sarcoma	0.000173	0.00108	CbGpPWpGaD
Lamotrigine—Nausea—Doxorubicin—sarcoma	0.000172	0.000236	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—VEGFA—sarcoma	0.000172	0.00107	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—VEGFA—sarcoma	0.000172	0.00107	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—SRC—sarcoma	0.00017	0.00106	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—SRC—sarcoma	0.00017	0.00106	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—NRAS—sarcoma	0.00017	0.00106	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—NRAS—sarcoma	0.00017	0.00106	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—EGFR—sarcoma	0.000168	0.00105	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—HRAS—sarcoma	0.000168	0.00105	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—HRAS—sarcoma	0.000168	0.00105	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—SRC—sarcoma	0.000168	0.00104	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—HRAS—sarcoma	0.000167	0.00104	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—VEGFA—sarcoma	0.000167	0.00104	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—VEGFA—sarcoma	0.000166	0.00103	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—VEGFA—sarcoma	0.000166	0.00103	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—NRAS—sarcoma	0.000164	0.00102	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—NRAS—sarcoma	0.000164	0.00102	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—VEGFA—sarcoma	0.000163	0.00102	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—NRAS—sarcoma	0.000161	0.00101	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EGFR—sarcoma	0.000161	0.001	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—KRAS—sarcoma	0.000159	0.000991	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—EGFR—sarcoma	0.000155	0.000964	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EGFR—sarcoma	0.000155	0.000964	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—KRAS—sarcoma	0.000152	0.000948	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PLCG1—sarcoma	0.000149	0.000931	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—EGFR—sarcoma	0.000149	0.000929	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EGFR—sarcoma	0.000149	0.000929	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—EGFR—sarcoma	0.000147	0.000916	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—KRAS—sarcoma	0.000146	0.000911	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—KRAS—sarcoma	0.000146	0.000911	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—KRAS—sarcoma	0.000141	0.000878	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—KRAS—sarcoma	0.000141	0.000878	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—KRAS—sarcoma	0.000139	0.000865	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—HRAS—sarcoma	0.000135	0.000842	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—CTNNB1—sarcoma	0.000132	0.000825	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000131	0.000817	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—HRAS—sarcoma	0.000129	0.000806	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—HRAS—sarcoma	0.000124	0.000774	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—HRAS—sarcoma	0.000124	0.000774	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—HRAS—sarcoma	0.00012	0.000746	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—HRAS—sarcoma	0.00012	0.000746	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—SRC—sarcoma	0.00012	0.000746	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—HRAS—sarcoma	0.000118	0.000735	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—VEGFA—sarcoma	0.000116	0.000726	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—NRAS—sarcoma	0.000115	0.000717	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000108	0.000676	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EGFR—sarcoma	0.000105	0.000653	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—KRAS—sarcoma	9.9e-05	0.000617	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	9.44e-05	0.000589	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	9.42e-05	0.000587	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	9.35e-05	0.000583	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	8.45e-05	0.000527	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—HRAS—sarcoma	8.41e-05	0.000525	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	8.23e-05	0.000513	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	7.57e-05	0.000472	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	7.41e-05	0.000462	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	7e-05	0.000436	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	6.22e-05	0.000388	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—ENO2—sarcoma	5.58e-05	0.000348	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—HBA1—sarcoma	5.54e-05	0.000346	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PLCG1—sarcoma	4.73e-05	0.000295	CbGpPWpGaD
